Stock Events

Stock Events

Search...

Madrigal Pharmaceuticals (MDGL) Q3 2023 Earnings

6NovConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-5.34

-4.97

-4.6

-4.23

Details

Expected EPS

-4.92

Actual EPS

-5.34

Surprise EPS

-0.42

Surprise Percent

+8.54%

Description

Madrigal Pharmaceuticals (MDGL) has reported earnings of -5.34 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.